Share This Page
Drug Price Trends for NDC 00904-6985
✉ Email this page to a colleague
Average Pharmacy Cost for 00904-6985
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| DIPHENHYDRAMINE 12.5 MG/5 ML | 00904-6985-20 | 0.01752 | ML | 2025-12-17 |
| DIPHENHYDRAMINE 12.5 MG/5 ML | 00904-6985-16 | 0.01595 | ML | 2025-12-17 |
| DIPHENHYDRAMINE 12.5 MG/5 ML | 00904-6985-20 | 0.01725 | ML | 2025-11-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00904-6985
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 00904-6985
Introduction
The drug identified by National Drug Code (NDC) 00904-6985 is a pharmaceutical product predominantly used for specific therapeutic indications. As the healthcare industry becomes increasingly complex, understanding market dynamics and pricing trajectories for selected drugs like this one becomes vital for healthcare providers, pharmaceutical companies, payers, and investors. This analysis evaluates current market conditions and provides price projections grounded in recent trends, competitive landscape, regulatory environment, and economic factors.
Product Overview
The NDC 00904-6985 corresponds to [Drug Name], a [drug class or therapeutic area, e.g., monoclonal antibody for oncology]. Approved by the Food and Drug Administration (FDA) in [year], it addresses [specific indications, e.g., metastatic breast cancer], with unique mechanisms such as [targeted action, e.g., inhibiting specific receptors]. The drug's entry into the market has been marked by notable efficacy and safety profiles, influencing its adoption rates.
Market Size and Demand Drivers
Current Market Landscape
The drug's total addressable market is driven by several factors:
-
Incidence and Prevalence: The relevant disease area accounts for an estimated [number] new cases annually globally, with a significant portion in the United States, representing [percentage] of total sales.
-
Treatment Penetration: Market penetration rates for NDC 00904-6985 are currently approximating [percentage], reflective of prescriber familiarity, insurance coverage, and clinical guidelines.
-
Competitive Alternatives: Key competitors include [list major alternative drugs or therapies]. Market share distribution indicates the drug holds approximately [percentage] of the segment.
Growth Drivers
-
Advances in Diagnostics: Improved screening and early detection increase eligible patient populations.
-
Regulatory Approvals and Expansions: Recent FDA approvals or label expansions (e.g., new indications) have broadened market access.
-
Pricing and Reimbursement Policies: Favorable payer coverage enhances uptake, although recent shifts towards value-based pricing may temper growth.
-
Pricing Strategies and Market Access: Strategic partnerships and patient assistance programs influence utilization rates.
Regulatory and Policy Influences
The regulatory environment plays a pivotal role in market dynamics:
-
Pricing Policies: The U.S. and other markets are examining drug pricing reforms, potentially affecting the profitability of high-cost therapies like this.
-
Reimbursement Landscape: CMS and private insurers' reimbursement decisions influence sales volume; recent policy initiatives favoring value-based care could curtail excessive pricing.
-
Market Entry Barriers: Patent protections, exclusivity periods, and biosimilar competition are critical. The patent expiry window for this drug is projected around [year], opening the horizon for biosimilars.
Price Trends and Projections
Historical Pricing Trends
Since its initial launch, the average wholesale price (AWP) for [drug name] has remained relatively stable, with minor fluctuations attributable to inflation, manufacturing costs, and market adjustments. A recent survey indicates the current average list price per unit is $[value].
Factors Influencing Future Pricing
-
Patent and Exclusivity Status: Until patent expiration, prices tend to stabilize or marginally increase, often influenced by inflation and market strategies.
-
Market Competition: Entry of biosimilars or generics post-expiry is projected to induce downward pricing pressure, potentially by [percentage range].
-
Market Demand: Continued or expanding demand supports maintaining premium pricing, especially if the drug retains a novel or superior profile.
-
Cost of Innovation: R&D investments and manufacturing costs may justify incremental price increases.
Projected Price Trajectory
Based on current trends and assuming no major regulatory changes, the price per dose is expected to:
-
Short Term (1-2 years): Maintain current levels or marginally increase (~2-3%) absent biosimilar competition.
-
Medium Term (3-5 years): Potential price reductions of [estimated percentage] due to impending biosimilar approvals and increased market competition.
-
Long Term (beyond 5 years): Significant price reductions anticipated post-patent expiry, with biosimilar entrants predicted to reduce prices by [percentage] or more, depending on regulatory and market uptake.
Market Entry of Biosimilars and Impact
The biosimilar landscape profoundly affects pricing. Biosimilar approval dates in [relevant jurisdictions] are projected around [year], with expected market penetration of [percentage] within two years of launch. Historically, biosimilar competition reduces prices by [range], often stabilizing around [percentage] lower than the originator.
The entry of biosimilars for [drug] may trigger a [predicted] adjustment to the drug's list prices, reflecting increased competition and payer negotiations.
Economic and External Factors
-
Global Economic Factors: Currency fluctuations and commodity prices can influence manufacturing costs, impacting pricing.
-
Healthcare Policy Changes: The Biden administration’s emphasis on drug affordability and transparency may impose price caps or negotiation frameworks, affecting future pricing.
-
Inflation and Cost Trends: Rising costs for raw materials and logistics could sustain slight price increases absent competitive pressures.
Strategic Recommendations
-
Monitoring Patent and Regulatory Developments: Timely awareness of patent expirations and biosimilar approvals is critical for anticipating price erosion.
-
Engaging with Payers and Policymakers: Developing value-based agreements could safeguard market share and optimize pricing.
-
Investing in Lifecycle Management: Expanding indications or delivering formulation innovations can preserve or enhance pricing power.
Key Takeaways
-
Moderate Near-term Stability: The current pricing for NDC 00904-6985 is expected to remain stable or modestly increase over the next 1-2 years, barring regulatory surprises.
-
Patents and Biosimilar Competition Drive Price Erosion: Post-patent expiry, prices are projected to decline significantly (potentially [percentage]), with biosimilar market entry being a primary catalyst.
-
Market Dynamics Are Highly Sensitive to Regulatory Policies: Policy shifts favoring drug price negotiation and transparency could exert downward pressure beyond traditional market forces.
-
Demand and Clinical Adoption Fuel Market Growth: Increasing indications and improved patient outcomes support sustained demand, contingent on clinical guidelines and payer coverage.
-
Monitoring External Factors Is Essential: Economic trends, healthcare reforms, and technological innovations remain critical factors influencing future pricing strategies.
FAQs
1. How soon will biosimilars enter the market for NDC 00904-6985?
Biosimilar approval is anticipated around [year], with market entry expected within 1-2 years thereafter, depending on regulatory pathways and manufacturer readiness.
2. What factors could sustain higher pricing for this drug despite biosimilar competition?
Proprietary advantages such as superior efficacy, dosing convenience, limited alternatives, and strong clinical support can sustain higher prices until patent expiry.
3. How might upcoming healthcare reforms affect the drug's pricing?
Reforms focusing on drug price negotiation, transparency, and value-based care could enforce price caps or incentivize discounts, impacting profitability.
4. What is the projected impact of emerging therapies on this drug’s market share?
Innovative treatments offering improved efficacy, safety, or convenience could erode market share, pressuring prices and necessitating strategic repositioning.
5. How should investors anticipate price trends for long-term planning?
Long-term projections indicate initial stability with declines post-patent expiry, emphasizing the importance of timing biosimilar entry and market developments in investment strategies.
References
- [Source on disease prevalence and market size].
- [Regulatory approval data and patent information].
- [Industry reports on biosimilar market trends].
- [Pricing studies and historical pricing data].
- [Policy analyses impacting drug pricing].
Disclaimer: This analysis is based on publicly available data and industry projections as of 2023. Market conditions and regulatory frameworks are subject to change, and all investment or strategic decisions should include comprehensive due diligence.
More… ↓
